Modulation of growth factor and cytokine expression by nitric oxide during rat colon anastomotic healing

David T Efron1, Daniel Most, Han Ping Shi

  • 1Department of Surgery, Sinai Hospital of Baltimore and The Johns Hopkins Medical Institutions, Baltimore, MD, USA

Insights

Inhibiting inducible nitric oxide synthase (iNOS) impairs colon healing and alters growth factor expression. This study shows nitric oxide (NO) is crucial for regulating gene expression during wound healing.

Area of Science:

  • Gastroenterology
  • Surgical Research
  • Molecular Biology

Background:

  • Nitric oxide (NO) generated by inducible nitric oxide synthase (iNOS) is crucial for colon anastomotic healing.
  • Disruption of iNOS activity may alter growth factor expression during healing.

Purpose of the Study:

  • To assess if inhibiting iNOS activity affects growth factor expression during colon anastomotic healing.
  • To investigate the role of NO in modulating gene expression during wound healing.

Main Methods:

  • Male Sprague-Dawley rats underwent distal colonic anastomosis.
  • One group received L-N-iminoethyl-lysine (L-NIL), a selective iNOS inhibitor; controls received saline.
  • Anastomotic bursting pressure and growth factor mRNA expression (in situ hybridization) were analyzed on postoperative day 5.

Main Results:

  • L-NIL treatment reduced wound fluid NO(X) and anastomotic bursting pressure.
  • L-NIL significantly increased expression of transforming growth factor-beta, tumor necrosis factor-alpha, and vascular endothelial growth factor.
  • Expression of inducible and endothelial nitric oxide synthase mRNA also increased with L-NIL treatment.

Conclusions:

  • iNOS inhibition disrupts the normal profile of cytokine and growth factor mRNA during colon anastomotic healing.
  • This study provides in vivo evidence that NO modulates gene expression critical for wound healing.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...